$19.88-0.45 (-2.21%)
CoreCivic, Inc.
CoreCivic, Inc. in the Industrials sector is trading at $19.88. The stock is currently 14% below its 52-week high of $23.20, remaining 3.1% above its 200-day moving average. Technical signals show neutral RSI of 45 and bearish MACD signal, explaining why CXW maintains its current momentum and trend strength. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
CoreCivic, Inc. owns and operates partnership correctional, detention, and residential reentry facilities in the United States. It operates through three segments: CoreCivic Safety, CoreCivic Community, and CoreCivic Properties. The company provides ...
Recent performance snapshot CoreCivic (CXW) has been relatively steady, with the stock up slightly over the past week and month. It has also shown a stronger gain over the past 3 months, despite a decline over the past year. See our latest analysis for CoreCivic. Recent trading has been choppy, with the share price down 6.83% over the past day but still showing an 8.77% 90 day share price return and a much stronger 3 year total shareholder return of 129.46%. This suggests longer term momentum...
CoreCivic (NYSE:CXW) reported stronger first-quarter 2026 results and raised its full-year outlook, citing higher demand from federal immigration authorities, the activation of previously idle facilities and the acquisition of Clinical Solutions Pharmacy. President and Chief Executive Officer Patri
Participating on today's call are Patrick Swindle, CoreCivic, Inc.'s President and Chief Executive Officer, and David M. Garfinkle, our Chief Financial Officer. On this call, we will discuss financial results for the first quarter of 2026 as well as updated financial guidance for full-year 2026.
Moby summary of CoreCivic, Inc.'s Q1 2026 earnings call
Private prison operator CoreCivic (NYSE:CXW) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 25.8% year on year to $614.7 million. Its non-GAAP profit of $0.40 per share was 35.6% above analysts’ consensus estimates.